Positron emission tomography (PET) - its potential to provide surrogate markers in ALS

Amyotrophic Lateral Sclerosis

Volumn 1, Issue 4, 2000, Pages s17-s22

  Turner, Martin R ^a   Leigh, P Nigel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ALS; motor neuron disease; positron emission tomography

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; REVIEW; SCINTISCANNING;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0001834969     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/54-14660820050515665     Document Type: Article

References (50)

1. Paans AM. Positron Emission Tomography: background, possibilities and perspectives in neuroscience. Acta Neurol Belg 1997; 97: 150-153. (Pubitemid 127514835)
2. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 1996; 23: 207-211. (Pubitemid 26057001)
3. Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol 1987; 22: 580-586. (Pubitemid 17162899)
4. Hatazawa J, Brooks RA, Dalakas MC, Mansi L, Di Chiro G. Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: A PET Study. J Comput Assist Tomogr 1988; 12: 630-636.
5. Ludolph AC, Langen KJ, Regard M, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 1992; 85: 81-89.
6. Tanaka M, Kondo S, Hirai S, Sun X, Yamagishi T, Okamoto K. Cerebral blood flow and oxygen metabolism in progressive dementia associated with amyotrophic lateral sclerosis. J Neurol Sci 1993; 120: 22-28. (Pubitemid 24011143)
7. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217-247. (Pubitemid 12183320)
8. Kew JM, Leigh PN. Dementia with motor neuron disease. In: Rossor MN (ed.). Unusual dementias. In Bailliere's Clinical Neurology, Vol. 1, No. 3. London: Bailliere Tindall, 1992.
9. Smith MC. Nerve fibre degeneration in the brain in amyo-trophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1960; 23: 269-282.
10. David AS, Gillham RA. Neuropsychology study of motor neuron disease. Psychosomatics 1986; 27: 441-445. (Pubitemid 16094553)
11. Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A. Cognitive impairment in motor neuron disease. Acta Neurol Scand 1985; 71: 480-484. (Pubitemid 15002114)
12. Gallassi R, Montagna P, Morreale A, et al. Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease. Eur Neurol 1989; 29: 115-120. (Pubitemid 19077108)
13. Perry TL, Hansen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987; 37: 1845-1848. (Pubitemid 18026363)
14. Hoffman JM, Mazziotta JC, Hawk TC, Sumida R. Cerebral glucose utilization in motor neuron disease. Arch Neurol 1992; 49: 849-854.
15. Colebatch JG, Deiber MP, Passingham RE, et al. Regional cerebral blood flow during voluntary arm and hand movements in human subjects. J Neurophysiol 1991; 65: 1392-1401.
16. Chollet F, DiPiero V, Wise RJ, Brooks DJ, Dolan RJ, Frack-owiak RS. The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 1991; 29: 63-71.
17. Frith CD, Friston KJ, Liddle PF, Frackowiak RS. PET imaging and cognition in schizophrenia. J R Soc Med 1992; 85: 222-224.
18. Liddle PF, Friston KJ, Frith CD, Frackowiak RS. Cerebral blood low and mental processes in schizophrenia. J R Soc Med 1992; 85; 224-227.
19. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 1992; 32: 151-161.
20. Weiller C, Chollet F, Friston KJ, Wise RJ, Frackowiak RS. Functional reorganization of the brain in recovery from stria-tocapsular infarction in man. Ann Neurol 1992; 31: 463-472.
21. Kew JJ, Leigh PN, Playford ED, et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 1993; 116: 655-680. (Pubitemid 23203643)
22. Kew JJ, Goldstein LH, Leigh PN, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsycho-logical and positron emission tomography study. Brain 1993; 116: 1399-1423. (Pubitemid 24038859)
23. Deiber MP, Passingham RE, Colebatch JG, Friston KJ, Nixon PD, Frackowiak RS. Cortical areas and the selection of movement: a study with positron emission tomography. Exp Brain Res 1991; 84: 393-402.
24. Lammertsma AA, Cunningham VJ, Deiber MP, et al. Combination of dynamic and integral methods for generating reproducible functional CBF images. J Cereb Blood Flow Metab 1990; 10: 675-686. (Pubitemid 20260949)
25. Friston KJ, Passingham RE, Nutt JG, Heather JD, Sawle GV, Frackowiak RS. Localisation in PET images: direct itting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab 1989; 9: 690-695. (Pubitemid 19239490)
26. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Plastic transformation of PET images. J Comput Assist Tomogr 1991; 15: 634-639.
27. Friston KJ, Frith CD, Liddle PF, Frackowiak RS. Comparing functional (PET) images: the assessment of signiicant change. J Cereb Blood Flow Metab 1991; 11: 690-699.
28. Kew JJ, Brooks DJ, Passingham RE, Rothwell JC, Frackowiak RS, Leigh PN. Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a comparative PET study. Neurology 1994; 44: 1101-1110. (Pubitemid 24188186)
29. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 1996; 119: 2105-2120.
30. Ellis CM, et al. Abstract from the proceedings of American Academy Meeting, San Diego, April 2000. Neurology (in press).
31. Snow BJ, Peppard RF, Guttman M, et al. Positron emission tomographic scanning demonstrates a presynaptic dopamin-ergic lesion in Lytico-Bodig. The amyotrophic lateral scler-osis-parkinsonism-dementia complex of Guam. Arch Neurol 1990; 47: 870-874. (Pubitemid 20251717)
32. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 1993; 342: 1016-1018. (Pubitemid 23314803)
33. Burrow JN, Blumbergs PC. Substantia nigra degeneration in motor neuron disease: a quantitative study. Aust N Z J Med 1992; 22: 469-472.
34. Kato S, Oda M, Tanabe H. Dimunition of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993; 19: 300-304. (Pubitemid 23237480)
35. 11 C-flumazenil PET study. Ann Neurol 1996; 40: 188-198.
36. 11C- lumazenil PET in neocortical epilepsy. Neurology 1998; 51: 485-492. (Pubitemid 28406326)
37. Nihei K, McKee AC, Kowall NW. GABAergic local circuit neurons degenerate in the motor cortex of amyotrophic lateral sclerosis patients. Society for Neuroscience Abstracts 1992; 18: 1249.
38. Ferrer I, Tunon T, Serrano MT, et al. Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis. J Neurol Neu-rosurg Psychiatry 1993; 56 (3): 257-261. (Pubitemid 23101205)
39. Ince P, Stout N, Shaw P, et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropath Appl Neurobiol 1993; 19: 291-299. (Pubitemid 23237479)
40. 11
41. 3H]PK 11195, an isoquinolone carboxamide derivative: kinetic studies and autoradiographic localization. J Neurochem 1983; 41: 1744-1750. (Pubitemid 14204786)
42. Vowinckel E, Reutens D, Becher B, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res 1997; 50: 345-353. (Pubitemid 27473649)
43. 123I]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation. Eur J Nucl Med 1999; 26: 194-200. (Pubitemid 29139847)
44. Troost D, Van den Oord JJ, Vianney de Jong JMB. Immuno-histochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neuro-biol 1990; 16: 401-410. (Pubitemid 20334861)
45. Banati RB, Myers R, Goerres G, et al. Imaging microglial activation in vivo. J Cereb Blood Flow Metab 1997; 17 (suppl): 435.
46. Gehlert DR, Stephenson DT, Schober DA, Rash K, Clemens JA. Increased expression of peripheral benzodiazepine receptors in the facial nucleus following motor neuron axotomy. Neurochem Int 1997; 31: 705-713. (Pubitemid 27425080)
47. 11 C]diprenorphine. J Cereb Blood Flow Metab 1993; 13 (suppl): S792.
48. Dagher A, Gunn R, Lockwood G, et al. A new method for the measurement of neurotransmitter release in man using positron emission tomography. J Neural Transm 1996; 103: XXVII-XXVI0.
49. Ellis CM, Simmons A, Jones DK, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999; 53: 1051-1058. (Pubitemid 29442122)
50. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SCR, Leigh PN. A proton magnetic resonance spectroscopic study in ALS. Neurology 1998; 51: 1104-1109.